1. Sinovac Covid-19 vaccine offered by Chinese city costs US$60  Free Malaysia Today
  2. $60 experimental coronavirus vaccine rolled out in eastern Chinese city  Deccan Herald
  3. Chinese experimental Covid-19 vaccine is safe and produces an immune response  Daily Mail
  4. Coronavirus vaccine candidate from China's CNBG shows promise in human test, study shows  Yahoo! Voices
  5. Sinovac Coronavirus Vaccine Offered by Chinese City for Emergency Use Costs $60  News18
  6. View Full coverage on Google News

BEIJING (Reuters) - A Chinese city is offering Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60 (£46).BEIJING (Reuters) - A Chinese city is offering Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60 (£46).

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60 | The Star

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.

Coronavirus: Experimental £46 COVID-19 vaccine is made available to residents of Chinese city | Daily Mail Online

An open letter from the frontrunner COVID-19 vaccine producer published Friday ends any expectations a vaccine might be available before Election Day.An open letter from the frontrunner COVID-19 vaccine producer published Friday ends any expectations a vaccine might be available before Election Day.

Pfizer CEO letter makes Thanksgiving earliest date for COVID-19 vaccine

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.

China's Covid-19 vax is safe, prompts antibody response: Lancet | greatandhra.com

Health authorities in Jiaxing, East China’s Zhejiang Province, announced on Thursday that the city has been administering China’s homegrown inactivated COVID-19 vaccines among high-risk groups and would gradually offer it to ordinary citizens for urgent use.

Eastern Chinese cities to offer ordinary citizens COVID-19 vaccines - Global Times

The chief executive of Pfizer said on Friday that the company would not apply for emergency authorization of its coronavirus vaccine before the third week of November, ruling out President Donald Trump’s assertion that a vaccine would be ready before Election Day on Nov. 3.The chief executive of Pfizer said on Friday that the company would not apply for emergency authorization of its coronavirus vaccine before the third week of November, ruling out President Donald

Won’t seek vaccine authorization before mid-November: Pfizer | Deccan Herald

The pharmaceutical giant just laid out a timetable for when it expects to be able to meet the FDA's EUA application requirements for BNT162.The pharmaceutical giant just laid out a timetable for when it expects to be able to meet the FDA's EUA application requirements for BNT162.

Pfizer Hopes to Apply for Coronavirus Vaccine Emegency Use Authorization in November | The Motley Fool

Pfizer CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes wellPfizer CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well

A Chinese drug developer is offering an experimental coronavirus vaccine to students going abroad in a strategy health experts say raises safety and ethical concerns. China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinicalA Chinese drug developer is offering an experimental coronavirus vaccine to students going abroad in a strategy health experts say raises safety and ethical concerns. China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinical

Chinese company offers coronavirus vaccine to students

A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study | Health

Trump, Biden square off in dueling town halls, U.S. Covid-19 cases reach a third peak, date set for committee vote on Barrett nomination, and other news to start your day. Trump, Biden square off in dueling town halls, U.S. Covid-19 cases reach a third peak, date set for committee vote on Barrett nomination, and other news to start your day.

Pfizer and BioNTech Vaccine Could Be Ready By the End of November. We’re All Winners. | Barron's

The drug maker’s CEO said Pfizer plans to apply for emergency use authorization by late November.The drug maker’s CEO said Pfizer plans to apply for emergency use authorization by late November.

Pfizer won't be seeking emergency approval for coronavirus vaccine before election | TheHill

The drug maker’s CEO said Pfizer plans to apply for emergency use authorization by late November.The drug maker’s CEO said Pfizer plans to apply for emergency use authorization by late November.

Pfizer won't be seeking emergency approval for coronavirus vaccine before election | TheHill

Having struggled to contain the spread of the coronavirus, the country has put all its chips on securing access to an effective vaccine.Having struggled to contain the spread of the coronavirus, the country has put all its chips on securing access to an effective vaccine.

Indonesia Secures Access to Promising British COVID-19 Vaccine – The Diplomat

But that makes it unlikely a vaccine will be available before the US election which President Trump has promised.But that makes it unlikely a vaccine will be available before the US election which President Trump has promised.

search

WASHINGTON" The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after the Nov 3 US presidential election, it said on Friday.WASHINGTON" The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after the Nov 3 US presidential election, it said on Friday.

Pfizer to seek vaccine approval in November

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial ...

Preliminary results find COVID-19 vaccine candidate based on inactivated SARS-CoV-2 virus is safe

Side effects that have emerged in a large late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line with those seen in smaller early studies, a positive sign for one of the front-runners in the race for a shot.

Pfizer, BioNTech Vaccine Trial Remains on Track, CEO Says

Pfizer chief executive Albert Bourla confirmed Friday the company will not file for regulatory authorization until the third week of November.Pfizer chief executive Albert Bourla confirmed Friday the company will not file for regulatory authorization until the third week of November.

Pfizer says it will not have a coronavirus vaccine until late November, allaying fears of a rush for approval before Election Day - The Washington Post

The mRNA coronavirus vaccine being developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) is unlikely to become available ...The mRNA coronavirus vaccine being developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) is unlikely to become available under emergency use...

Pfizer, Inc. (NYSE:PFE), (BNTX) - Pfizer CEO: Emergency Use Application For Coronavirus Vaccine Could Come In Late November | Benzinga

Pfizer (PFE) stock is on the higher after the company announced it could submit an Emergency Use Authorization application by as soon as the end of November

Blue-Chip Drugmaker Moves Higher on Vaccine Announcement

Pfizer Inc <PFE.N> said on Friday it could file in late November for U.S. authorization of the COVID-19 vaccine it is developing, suggesting that a vaccine could potentially be available in the United States by the end of the year.Pfizer Inc <PFE.N> said on Friday it could file in late November for U.S. authorization of the COVID-19 vaccine it is developing, suggesting that a vaccine could potentially be available in the United States by the end of the year.

Pfizer says earliest U.S. filing for COVID-19 vaccine would be late November | Reuters

Vaccine developers must provide two months of safety data on half of the trial participants following the final dose of the vaccine.Vaccine developers must provide two months of safety data on half of the trial participants following the final dose of the vaccine.

According to the recent World Bank report, an estimated 1 billion students in developing nations may be out of school. CoronavirusA World Bank report says about 1 billion students in developing countries may be out of school due to the looming second wave of COVID-19.

1 billion students in developing nations may be out of school due to second wave of COVID-19 - World Bank | Nairametrics

The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.

Sinovac vaccine for Covid offered by Chinese city for emergency use costs $60 - world news - Hindustan Times

The latest statistics released by the Nigeria Centre for Disease Control (NCDC) show that there are 61,194 confirmed cases of COVID-19On the 16th of October 2020, 212 new confirmed cases and 3 deaths were recorded in Nigeria

COVID-19 Update in Nigeria | Nairametrics

A COVID-19 vaccine could arrive before the end of 2020, based on a timeline Pfizer's CEO laid out. In an open letter posted to Pfizer's website, CEO Albert Bourla wrote, "Assuming positive data, Pfizer will apply for emergency authorization use in the U. S. soon after the safety milestone is achieved in the third week of November. " COVID-19: Find the latest news on the outbreak in West Michigan by visiting the News Channel 3 coronavirus page.A COVID-19 vaccine could arrive before the end of 2020, based on a timeline Pfizer's CEO laid out. In an open letter posted to Pfizer's website, CEO Albert Bourla wrote, "Assuming positive data, Pfizer will apply for emergency authorization use in the U. S. soon after the safety milestone is achieved in the third week of November. " COVID-19: Find the latest news on the outbreak in West Michigan by visiting the News Channel 3 coronavirus page.

Pfizer could seek November vaccine authorization | WWMT

Pfizer could seek November vaccine authorization

NewZimbabwe.com – The Zimbabwe News You Trust is Zimbabwe’s leading online newspaper and published by New Zimbabwe Media Ltd. The platform brings you the latest breaking News, Business, Showbiz, Sports, Diaspora and gives you everything you’ve come to expect and love.Spread This NewsMailOnLine Hopes of getting a Covid-19 vaccine were boosted again today after an experimental Chinese jab was found to be safe and produce an immune response. Every volunteer given a double-dose of state-owned firm Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. In theory, this would protect them from catching

More Covid-19 vaccine hopes as scientists say experimental Chinese jab is safe - NewZimbabwe.com

Pharmaceutical giant Pfizer has put the kibosh on any dreams of rushing out its experimental covid-19 vaccine before the U.S. election day. The good news is that the company is optimistic that its vaccine will be ready to apply for the Food and Drug Administration’s emergency use authorization (EUA) by the end of November, raising hopes that it could see use in the U.S. before the end of 2020.Pharmaceutical giant Pfizer has put the kibosh on any dreams of rushing out its experimental covid-19 vaccine before the U.S. election day. The good news is that the company is optimistic that its vaccine will be ready to apply for the Food and Drug Administration’s emergency use authorization (EUA) by the end of November, raising hopes that it could see use in the U.S. before the end of 2020.

Pfizer Says Vaccine Could Be Ready for Review by Late November

The pharmaceutical company's timeline reduces the odds of a vaccine being approved before the election.The pharmaceutical company's timeline reduces the odds of a vaccine being approved before the election.

Pfizer's COVID-19 vaccine timeline aims "to ensure public trust" - Axios

China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.

Chinese firm giving unproven COVID-19 vaccine to students going abroad - Business Insider

China has already given essential workers at ports, hospitals and other high-risk areas across the country an experimental vaccine.. Read more at straitstimes.com.East Asia News -China has already given essential workers at ports, hospitals and other high-risk areas across the country an experimental vaccine.. Read more at straitstimes.com.

$80 unproven coronavirus vaccine rolled out in eastern Chinese city of Jiaxing, East Asia News & Top Stories - The Straits Times

Some states, including Wisconsin, are experiencing a strain on hospitals, as Pfizer announced today that it won't likely be able to apply for emergency use for its vaccine until a few weeks after the election.Some states, including Wisconsin, are experiencing a strain on hospitals, as Pfizer announced today that it won't likely be able to apply for emergency use for its vaccine until a few weeks after the election.

US surpasses 8 million COVID-19 cases | CIDRAP

US pharmaceutical giant Pfizer expects to file for emergency use authorization for its Covid-19 vaccine in late November, around two weeks after the November 3 US presidential election, it said Frida…US pharmaceutical giant Pfizer expects to file for emergency use authorization for its Covid-19 vaccine in late November, around two weeks after the November 3 US presidential election, it said Frida…

Pfizer plans to seek authorization for Covid-19 vaccine next month

BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...

US$60 experimental COVID-19 vaccine rolled out in east Chinese city - CNA

Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.

Chinese Covid-19 vaccine found to be safe on humans: Study - News | Khaleej Times

Pfizer said that it would likely seek emergency approval for a COVID-19 vaccine in late November, citing recent federal guidance that toughened approval…Pfizer Announcement All But Ends Worries About Pre-Election Day Vaccine Campaign Prop

Pfizer Announcement All But Ends Worries About Pre-Election Day Vaccine Campaign Prop | Talking Points Memo